Comment on

• Rivaroxaban for thromboprophylaxis in acutely ill medical patients.

  Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, Tapson V; MAGELLAN Investigators. Cohen AT, et al. N Engl J Med. 2013 Feb 7;368(6):513-23. doi: 10.1056/NEJMoa1111096. N Engl J Med. 2013. PMID: 23388003 Clinical Trial.
• Rivaroxaban for thromboprophylaxis in acutely ill medical patients.

  Alameddine R, Husari A. Alameddine R, et al. N Engl J Med. 2013 May 16;368(20):1944-5. doi: 10.1056/NEJMc1303641. N Engl J Med. 2013. PMID: 23675666 No abstract available.
• Rivaroxaban for thromboprophylaxis in acutely ill medical patients.

  Derksen RJ, Mulder WM, Mulder JW. Derksen RJ, et al. N Engl J Med. 2013 May 16;368(20):1945. doi: 10.1056/NEJMc1303641. N Engl J Med. 2013. PMID: 23675667 No abstract available.
• Rivaroxaban for thromboprophylaxis in acutely ill medical patients.

  Vink R, Sohne M. Vink R, et al. N Engl J Med. 2013 May 16;368(20):1945. doi: 10.1056/NEJMc1303641. N Engl J Med. 2013. PMID: 23675668 No abstract available.